Specifically, some studies indicate that the expression of the matrix metalloproteinase 9 (MMP-9), one protein implicated in neuroplasticity, is increased in patients with depression, and these levels are reduced after antidepressant treatment. Here, MMP9 is linked to major depressive disorder.